Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.
EKF Diagnostics Holdings has repurchased 240,000 of its ordinary shares at a volume-weighted average price of 25.7 pence, with the shares to be held in treasury, leaving 432,580,112 ordinary shares carrying voting rights out of a total issued share capital of 435,383,092. As part of the buyback, the company acquired 70,000 shares from funds managed by Harwood to ensure that non-executive director Christopher Mills’ aggregate indirect beneficial interest, now at 127,561,000 shares, remains at approximately the same level and does not exceed 30% of EKF’s total voting rights, a move that helps manage shareholder concentration and regulatory thresholds while signalling continued capital management activity by the group.
The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.
Spark’s Take on GB:EKF Stock
According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.
EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.
To see Spark’s full report on GB:EKF stock, click here.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings is an AIM-listed global diagnostics company specialising in point-of-care analysers for haematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the group operates five manufacturing sites across the US and Germany and sells its products into more than 120 countries worldwide.
Average Trading Volume: 457,160
Technical Sentiment Signal: Sell
Current Market Cap: £112.2M
Learn more about EKF stock on TipRanks’ Stock Analysis page.